These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26865942)

  • 1. Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles.
    Khalili I; Ghadimipour R; Sadigh Eteghad S; Fathi Najafi M; Ebrahimi MM; Godsian N; Sefidi Heris Y; Khalili MT
    Jundishapur J Microbiol; 2015 Dec; 8(12):e27035. PubMed ID: 26865942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxymethyl chitosan bounded iron oxide nanoparticles and gamma-irradiated avian influenza subtype H9N2 vaccine to development of immunity on mouse and chicken.
    Motamedi-Sedeh F; Saboorizadeh A; Khalili I; Sharbatdaran M; Wijewardana V; Arbabi A
    Vet Med Sci; 2022 Mar; 8(2):626-634. PubMed ID: 34878724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles.
    Mohamed SH; Arafa AS; Mady WH; Fahmy HA; Omer LM; Morsi RE
    Biologicals; 2018 Jan; 51():46-53. PubMed ID: 29126666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
    Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
    Park JK; Lee DH; Cho CH; Yuk SS; To EO; Kwon JH; Noh JY; Kim BY; Choi SW; Shim BS; Song MK; Lee JB; Park SY; Choi IS; Song CS
    Vet Microbiol; 2014 Mar; 169(3-4):211-7. PubMed ID: 24472228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus.
    Shahsavandi S; Ebrahimi MM; Fotouhi F; Tebianian M
    Viral Immunol; 2022 Jun; 35(5):365-374. PubMed ID: 35527642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of key immune protection factors in H9N2 avian influenza viruses infected and immunized specific pathogen-free chicken.
    Dai M; Li S; Keyi Shi ; Sun H; Zhao L; Deshui Yu ; Liao J; Xu C; Liao M
    Poult Sci; 2021 Jan; 100(1):39-46. PubMed ID: 33357705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants.
    Cahyani JI; Widyarini S; Wibowo MH
    Vet World; 2020 Nov; 13(11):2493-2501. PubMed ID: 33363346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies).
    Gharaibeh S; Amareen S
    Avian Dis; 2015 Dec; 59(4):508-11. PubMed ID: 26629624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks.
    Liu Y; Zhao D; Zhang J; Huang X; Han K; Liu Q; Yang J; Zhang L; Li Y
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.